The purification and characterization of a major glycoprotein of the murine mammary tumor virus

Immunological control of hematophagous arthropod vectors: utilization of novel antigens

Immunological control of ixodid ticks requires development of a vaccine that stimulates an effective anti-tick response. However, it is important to avoid induction of intense host skin reactivity to tick feeding. Salivary-gland-derived molecules are introduced into the host during ixodid engorgement; therefore, use of these moieties might not be an optimal immunization strategy. Antigens not normally involved in acquired resistance can be used to induce anti-tick immunity. These "novel" antigens, obtained from tick gut absorptive surface, are not introduced into the host during tick feeding, but are exposed to host-immune effector elements in the blood meal, resulting in ixodid rejection, prevention of ova production and death. Anti-tick immunity is induced with microgram quantities of this ixodid gut antigen preparation. Sera obtained from immunized animals were used to identify antibody-reactive components of the resistance-inducing extract. Tick gut absorptive surface antigen glycoconjugates were identified by lectin blotting, using a series of probes with different carbohydrate specificities. The lectins, peanut and wheat germ agglutinin, and immunized host antibodies bound extract components with similar molecular weights. Solubilization and fractionization of tick gut proteins with the non-ionic detergent Triton X-114 is described.

Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells

A unique subline of BALB/c mice, designated BALB/cV, exhibits an intermediate mammary tumor incidence (47%) and harbors a distinct milk-transmitted mouse mammary tumor virus (MMTV). The BALB/cV subline was used to study the molecular basis of potential virus-host interactions involving cell surface-expressed MMTV proteins. Cell surface iodination identified virus-specific proteins expressed on BALB/cV primary mammary tumor cells grown in culture. In contrast to (C3H)MMTV-producing cell lines which expressed MMTV gp52, BALB/cV tumor cells lacked gp52 and expressed instead a 68K, env-related protein. The 68Kenv protein was also detected on the surface of metabolically labeled BALB/cV tumor cells by an external immunoprecipitation technique. The expression of 68Kenv was restricted to mammary tissues of BALB/cV mice that also expressed other MMTV proteins. Biochemical analysis established that 68Kenv was not modified by N-linked glycosylation. 125I-labeled 68Kenv was rapidly released into the media of tumor cell cultures and was recovered both in the form of a soluble protein and in a 100,000 g pellet. The biologic function of this cell surface-expressed viral protein remains unknown.